You are here

Cellular Biomedicine

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies

BioSpace

Cellular Biomedicine

diffuse large B-cell lymphoma

Flag link:

A newly private Novartis partner bags a megaround on its first go to turbocharge CAR-T, cell therapy pipeline

A newly private Novartis partner bags a megaround on its first go to turbocharge CAR-T, cell therapy pipeline

Endpoints

Cellular Biomedicine

Flag link:

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

CP Wire

Cellular Biomedicine

osteoarthritis of the knee

Flag link:

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

Cellular Biomedicine

Flag link:

The Winners And Losers Of JP Morgan Monday

The Winners And Losers Of JP Morgan Monday

Forbes

Cellular Biomedicine

Alder Biopharmaceuticals

PTC Therapeutics

Axovant Sciences

Oxford Immunotec

Flag link: